Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations: The EAU-RF NIMBUS Trial

BACKGROUND: Adverse events induced by intravesical bacillus Calmette-Guérin (BCG) to treat high-grade non–muscle-invasive bladder cancer (NMIBC) often lead to treatment discontinuation. The EAU-RF NIMBUS trial found a reduced number of standard-dose BCG instillations to be inferior with the standard...

Descripción completa

Detalles Bibliográficos
Autores principales: van Straten, Christine G.J.I., Caris, Christien, Grimm, Marc-Oliver, Colombel, Marc, Muilwijk, Tim, Martínez-Piñeiro, Luis, Babjuk, Marko M., Türkeri, Levent N., Palou, Joan, Patel, Anup, Bjartell, Anders S., Witjes, Wim P.J., van der Heijden, Antoine G., Kiemeney, Lambertus A.L.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Bladder Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562176/
https://www.ncbi.nlm.nih.gov/pubmed/37822514
http://dx.doi.org/10.1016/j.euros.2023.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562176/
https://www.ncbi.nlm.nih.gov/pubmed/37822514
http://dx.doi.org/10.1016/j.euros.2023.08.004

Ejemplares similares